What's in maximiliano barahona vasquez's pipeline?

maximiliano barahona vasquez has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with maximiliano barahona vasquez's portfolio?

Top competitors by shared drug class: University of Aarhus.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/maximiliano-barahona-vasquez.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

maximiliano barahona vasquez — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

maximiliano barahona vasquez pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Gonyautoxins	Gonyautoxins	phase 3			Other
Chirocaine ketorolac epinephrine	Chirocaine ketorolac epinephrine	phase 3	Local anesthetic combination with NSAID and vasopressor	Voltage-gated sodium channels (chirocaine); COX-1/COX-2 (ketorolac); alpha-1 and beta-adrenergic receptors (epinephrine)	Pain Management, Surgery, Anesthesia

Therapeutic area mix

Other · 1
Pain Management, Surgery, Anesthesia · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

University of Aarhus · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for maximiliano barahona vasquez:

Cite this brief

Drug Landscape (2026). maximiliano barahona vasquez — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/maximiliano-barahona-vasquez. Accessed 2026-05-17.